Skip to content

Clinical trials

Phase 3 Cataract trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cataract Phase: Phase 3 Clear all

89 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20042
20054
20067
20073
20082
20093
20108
20118
20124
20137
20146
20153
20163
20171
20183
20193
20205
20212
20223
20241
20255

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed68
Recruiting7
Terminated6
Unknown status5
Withdrawn3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Alcon Research14
Bausch & Lomb Incorporated14
Abbott Medical Optics5
National Eye Institute (NEI)5
Glaukos Corporation3
Omeros Corporation3
EyePoint Pharmaceuticals, Inc.2
ICON Bioscience Inc2
Kala Pharmaceuticals, Inc.2
Salvat2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cataract89
Inflammation17
Pain12
Glaucoma7
Macular Degeneration4
Macular Edema4
Glaucoma, Open-Angle3
Diabetes Mellitus, Type 12
Diabetes Mellitus, Type 22
Neoplasms2

Trials

Showing 51 to 75 of 89. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.